Literature DB >> 12781080

[Prevalence of infections by hepatitis A, B, C and E viruses in two different socioeconomic groups of children from Santa Cruz, Bolivia].

Giuseppe M Gandolfo1, Giovanni M Ferri, Laura Conti, Anna Antenucci, Rosalia Marrone, Anna M Frasca, Gaetano Vitelli.   

Abstract

BACKGROUND AND OBJECTIVES: The epidemiology of hepatitis A, E, B and C was analyzed in 1,393 children living in Santa Cruz de la Sierra, Bolivia. They were distributed in two groups according to the social condition. MATERIALS AND
METHOD: 1,393 children were selected from two different schools: one attended by children belonging to a high social class of the town (group A), and the other school attended by children belonging to the poorest social class (group B). Blood samples were drawn by a team of physicians from Rome University La Sapienza. Serum antibodies against hepatitis A, B, C and E virus, and the hepatitis B surface antigen were evaluated by immunometric methods. The significance was evaluated using the *2 test.
RESULTS: Antibodies against hepatitis A virus were detected in 82% of examined children, with a significant difference between the two groups (56.3% vs 94.8%). The incidence of anti-HBc antibodies increased with age, so the infection is acquired prevalently in adolescence with a significant difference between both groups (1.1% vs 3.8%). The same phenomenon was observed with anti-HCV antibodies (4.7% positivity only in group B). Serum antibodies against hepatitis E virus were observed in 1.7% cases.
CONCLUSIONS: In Bolivia, as in other developing countries, viral hepatitis represents a serious burden for public health. Spreading of viral hepatitis can be controlled upon improving hygienic conditions and customs. Moreover, a vaccination plan against hepatitis A and B virus is necessary for the population living in endemic areas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12781080     DOI: 10.1016/s0025-7753(03)73826-3

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  2 in total

1.  Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes.

Authors:  Ryan M Taylor; Timothy Davern; Santiago Munoz; Stephen-Huy Han; Brendan McGuire; Anne M Larson; Linda Hynan; William M Lee; Robert J Fontana
Journal:  Hepatology       Date:  2006-12       Impact factor: 17.425

2.  Seroprevalence of Hepatitis A Virus, Hepatitis E Virus, and Helicobacter pylori in Rural Communities of the Bolivian Chaco, 2013.

Authors:  Irene Campolmi; Michele Spinicci; David Rojo Mayaregua; Herlan Gamboa Barahona; Antonia Mantella; Yunni Lara; Mimmo Roselli; Marianne Strohmeyer; Giampaolo Corti; Francesco Tolari; Joaquín Monasterio Pinckert; Harry R Dalton; Alessandro Bartoloni
Journal:  Am J Trop Med Hyg       Date:  2018-03-22       Impact factor: 2.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.